ReviewFrontiers in immunology2015

Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.

Hanno M Specht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.